FindTrial
Sign In

Effect on contrast sensitivity and ocular surface with different formulations of preservative free drug in glaucoma patients

Effect on contrast sensitivity and ocular surface with different formulations of preservative free topical Travoprost in treatment naive Primary open angle glaucoma patients - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085631
Enrollment
18
Registered
2025-04-25
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H401- Open-angle glaucoma

Interventions

Intervention1: Travoflo: Travoprost + ionic buffer as preservative Control Intervention1: Travatan: Travoprost + Polyquad as preservative

Sponsors

Dr Vidushi Postgraduate Junior Resident Ophthalmology GMCH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed as having primary open angle glaucoma

Exclusion criteria

Exclusion criteria: Patients with history of incisional or laser eye surgery in the past 3 months Any cause for visual impairment other than glaucoma Any medical condition which in the investigator"s opinion would preclude the patient from providing reliable and valid data Best-corrected visual acuity (BCVA) of less than 20/80 Any sign of secondary glaucoma, significant media opacities, and a history of using oral or topical steroids

Design outcomes

Primary

MeasureTime frame
Central and peripheral SPARCS Scores DEQ-5 values tFBUT Average RNFL thicknessTimepoint: Baseline, 1 month, 3months—

Secondary

MeasureTime frame
IOP Macular GCCTimepoint: 0, 1 and 3 months—

Countries

India

Contacts

Public ContactVidushi

Government Medical College and Hospital Chandigarh

itsdrparul@gmail.com9501071591

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026